High-Content Imaging-Based Screening for Anticancer Compounds in Zebrafish Xenografts

Area of Science:

• Comparative medicine
• Developmental biology
• Pharmacology

Background:

• Zebrafish larvae are transparent and small, facilitating phenotypic screening.
• Current methods for anticancer compound screening have limitations in throughput and biological relevance.
• Bridging in vitro and in vivo models is crucial for drug discovery.

Purpose of the Study:

• To establish a workflow for xenografting in zebrafish embryos and larvae.
• To enable automated high-content imaging-based screening of small compounds.
• To validate zebrafish xenografts as a vertebrate model for anticancer drug screening.

Main Methods:

• Development of a standardized xenografting protocol in zebrafish embryos/larvae.
• Implementation of automated high-content imaging for phenotypic analysis.
• Optimization of compound screening in a 96-well format using the zebrafish model.

Main Results:

• Successful establishment of a reproducible xenograft model in larval zebrafish.
• Demonstration of automated, high-content imaging for efficient data acquisition.
• Validation of the model's suitability for phenotypic screening of small compounds.

Conclusions:

• Zebrafish xenografts provide a powerful, high-throughput vertebrate system for anticancer compound screening.
• This model effectively bridges the gap between early-stage in vitro assays and later-stage in vivo studies.
• The described workflow enables efficient and automated drug discovery in a living organism.